|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Safety Problems Roil Pharma and FDA
Author(s)Jill Wechsler
Blockbuster drugs turn out to be risky business, while contamination problems shut down flu vaccine production.
Advertisement
Articles in this issue
about 21 years ago
In the Spotlight-December 2004about 21 years ago
December 2004about 21 years ago
Robust CRO Market Is Driving New Merger and Acquisition Activityabout 21 years ago
The Seventh Annual International Employment Surveyabout 21 years ago
Pharmaco-FakeryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
2
Six New and Nine Indication Extension Recommendations from EMA’s CHMP
3
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
4
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
5